Dr. Nikunj Jain
Co-Founder and HOD - Nuclear Medicine ,MBBS, DRM, DNB, FEBNM, FANMB, Dip. CBNC
The PSMA test is an advanced nuclear medicine imaging technique primarily used to detect and monitor prostate cancer. PSMA stands for Prostate-Specific Membrane Antigen, a protein found in higher concentrations on prostate cancer cells than in most normal tissues. This scan allows oncologists to identify cancer at an earlier stage and even detect small metastatic lesions that might otherwise remain unnoticed. As precision medicine becomes increasingly important, the PSMA test has become an essential part of prostate cancer diagnostics and treatment planning.
A PSMA test (usually performed as PSMA PET-CT or PSMA PET-MRI) involves the administration of a radioactive tracer designed to specifically target PSMA proteins on cancer cells. After the tracer circulates and binds to these cells, advanced imaging equipment such as PET-CT or PET-MRI is used to create detailed images showing where cancer is located in the body. This enables clinicians to see both the extent and activity of prostate cancer, supporting accurate staging, treatment planning, and follow-up.
PSMA imaging includes several types that help answer different clinical questions:
Combines functional imaging (from the tracer) with detailed anatomical images from CT.
Offers high-resolution soft tissue images along with functional imaging, often useful for pelvic and prostate areas.
While primarily diagnostic, PSMA targeting also plays a role in newer therapies like radioligand treatment, where radiation is delivered directly to cancer cells.
These variations allow clinicians to choose the most suitable option based on patient needs and the clinical scenario.
The PSMA test is highly versatile and has a range of applications:
Its ability to detect even small and early lesions makes PSMA imaging a game-changer in prostate cancer care.
The PSMA test procedure is straightforward and generally comfortable:
The total time spent in the imaging center is usually around 2–3 hours.
Patient can visit to any nearby diagnostic laboratory for PSMA test in Ghaziabad. Patient can click here for the appointment in molecular Diagnostic and Therapy Center for PSMA test. The center provides quality results at affordable price at Ghaziabad.
Patient can visit to any nearby diagnostic laboratory for PSMA test in Delhi or patient can click here for the appointment in molecular Diagnostic and Therapy Center for PSMA test. The center provides quality results at affordable price in Delhi.
The PSMA test has redefined how prostate cancer is diagnosed and monitored. By specifically targeting PSMA proteins that are abundant in prostate cancer cells, this scan offers unmatched sensitivity and accuracy. Whether used to detect newly diagnosed cancer, locate recurrences, or guide targeted therapies, PSMA imaging empowers clinicians to make more informed decisions—leading to better patient outcomes and personalized care.
A specialized nuclear imaging test designed to detect prostate cancer by targeting PSMA proteins.
By injecting a radioactive tracer that binds to cancer cells, followed by PET-CT or PET-MRI imaging.
No, the PSMA test itself is painless, aside from a brief needle prick during injection.
Usually 2–3 hours including preparation, waiting, and scanning.
Yes, fasting for a few hours is often recommended.
Yes, it involves a low dose of radiation and is generally considered very safe.
Patients with diagnosed or suspected prostate cancer, or those with rising PSA levels.
Yes, it is highly effective at locating metastases in lymph nodes, bones, and organs.
Your doctor will analyze the scan results to guide or adjust your treatment plan.
It is mainly diagnostic, but PSMA targeting is also used in some advanced therapeutic procedures.
Book tests, view reports, and manage your health records on the go. Experience convenient healthcare with Molecular Diagnostics and Therapy.